We are live on ! Find out more
DCM

DG Capital Management Portfolio holdings

AUM $326M
1-Year Est. Return 39.67%
This Fund
S&P 500
This Quarter Est. Return
+16.96%
1 Year Est. Return
+39.67%
3 Year Est. Return
+81.23%
5 Year Est. Return
+56.79%
10 Year Est. Return
–
AUM
$419M
AUM Growth
+$182M
Cap. Flow
+$118M
Cap. Flow %
28.25%
Top 10 Hldgs %
44%
Holding
139
New
103
Increased
12
Reduced
6
Closed
13

Top Buys

Rank Stock Value
1
DIN icon
Dine Brands
DIN
+$10M
2
AUPH icon
Aurinia Pharmaceuticals
AUPH
+$8.58M
3
ISPO
Inspirato
ISPO
+$8.07M
4
ATEX icon
Anterix
ATEX
+$8.05M
5
UTHR icon
United Therapeutics
UTHR
+$7.68M

Top Sells

Rank Stock Value
1
TVACU
Thayer Ventures Acquisition Corporation Units
TVACU
+$8.36M
2
PRVB
Provention Bio, Inc. Common Stock
PRVB
+$7.51M
3
FLACU
Frazier Lifesciences Acquisition Corporation Unit
FLACU
+$4.68M
4
BSX icon
Boston Scientific
BSX
+$4.16M
5
SCOAU
ScION Tech Growth I Unit
SCOAU
+$4.14M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 29.31%
2 Healthcare 16.91%
3 Financials 8.51%
4 Materials 4.27%
5 Consumer Staples 3.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UTHR icon
1
United Therapeutics
UTHR
$26.1B
$23.3M 5.57%
139,471
+46,055
+49% +$7.68M
STAY
2
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
$22.6M 5.39%
1,142,694
+202,003
+21% +$3.3M
AMRN
3
Amarin Corp
AMRN
$293M
$19.7M 4.71%
158,857
+47,784
+43% +$6.43M
SUM
4
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
$17.9M 4.27%
649,269
+102,321
+19% +$2.57M
BLMN icon
5
Bloomin' Brands
BLMN
$736M
$16.6M 3.98%
615,367
– –
EVRI
6
DELISTED
Everi Holdings
EVRI
$16.3M 3.9%
1,157,219
+65,907
+6% +$937K
HZNP
7
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$16.3M 3.9%
177,314
-4,300
-2% -$363K
EAT icon
8
Brinker International
EAT
$8.5B
$14.5M 3.46%
203,559
-2,000
-1% -$134K
TPB icon
9
Turning Point Brands
TPB
$1.56B
$14M 3.34%
268,360
+115,897
+76% +$5.78M
CZR icon
10
Caesars Entertainment
CZR
$6.1B
$12.4M 2.96%
141,516
+10,000
+8% +$839K
AZN icon
11
CALL
AstraZeneca
AZN
$267B
$12M 2.87%
121,000
+11,000
+10% +$1.11M
DIN icon
12
Dine Brands
DIN
$458M
$11.6M 2.77%
+128,824
New +$10M
DRI icon
13
CALL
Darden Restaurants
DRI
$23.7B
$11.4M 2.71%
80,000
– –
WH icon
14
Wyndham Hotels & Resorts
WH
$5.62B
$11.3M 2.69%
161,500
+66,000
+69% +$4.21M
BKEP
15
DELISTED
Blueknight Energy Partners L.P.
BKEP
$10M 2.39%
3,088,636
+641,199
+26% +$1.55M
FLL icon
16
Full House Resorts
FLL
$83.8M
$9.55M 2.28%
+1,121,928
New +$7.51M
ATEX icon
17
Anterix
ATEX
$1.78B
$9.22M 2.2%
+195,569
New +$8.05M
ISPO
18
DELISTED
Inspirato
ISPO
$7.9M 1.89%
+39,890
New +$8.07M
AUPH icon
19
Aurinia Pharmaceuticals
AUPH
$1.92B
$7.68M 1.83%
+591,154
New +$8.58M
EPWR
20
DELISTED
Empowerment & Inclusion Capital I Corp.
EPWR
$4.83M 1.15%
+500,000
New +$4.88M
GSAQ
21
DELISTED
Global Synergy Acquisition Corp. Class A Ordinary Shares
GSAQ
$4.56M 1.09%
+470,000
New +$4.62M
BIOTU
22
DELISTED
Biotech Acquisition Company Unit
BIOTU
$4.45M 1.06%
+450,000
New +$4.63M
FLAC
23
DELISTED
Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares
FLAC
$4.38M 1.05%
+440,000
New +$4.49M
TMTS
24
DELISTED
Spartacus Acquisition Corporation Class A Common Stock
TMTS
$4.13M 0.99%
417,861
+17,861
+4% +$182K
SSAAU
25
DELISTED
Science Strategic Acquisition Corp. Alpha Unit
SSAAU
$4.05M 0.97%
+407,944
New +$4.19M
1
2 3 4 5

Similar funds

ECH
ER Collective Holdings Washington, District of Columbia $326M AUM
CWM
Core Wealth Management Jupiter, Florida $326M AUM 14.89% 1-Year Est. Return
AFA
Alpha Financial Advisors Charlotte, North Carolina $326M AUM 15.49% 1-Year Est. Return
BCM
Boone Capital Management Atlanta, Georgia $326M AUM 86.31% 1-Year Est. Return
VSI
Verde Servicos Internacionais Sao Paulo, Brazil $326M AUM 26.99% 1-Year Est. Return
ISFAN
Investor's Fiduciary Advisor Network Snoqualmie, Washington $326M AUM 19.7% 1-Year Est. Return
JHWEPV
J. H. Whitney Equity Partners VI New Canaan, Connecticut $326M AUM
CCG
Ceeto Capital Group Coral Gables, Florida $326M AUM 24.81% 1-Year Est. Return

DG Capital Management's Q1 2021 Portfolio in Review

As of Q1 2021, DG Capital Management held 139 positions worth $419M, up 77% from $236M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

DG Capital Management deployed $118M of net new capital in Q1 2021, opening 103 new positions and adding to 12 existing holdings. Its largest new stake was Dine Brands: 128,824 shares worth $11.6M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 29% of assets, up from 29% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was BioCryst Pharmaceuticals, an estimated $3.45M trimmed.

  • DG Capital Management's largest Q1 2021 buy was Dine Brands: 128,824 shares worth $11.6M.
  • DG Capital Management added most to United Therapeutics in Q1 2021, an estimated $7.68M increase.
  • DG Capital Management's biggest Q1 2021 reduction was BioCryst Pharmaceuticals, cutting an estimated $3.45M.
  • DG Capital Management fully exited Thayer Ventures Acquisition Corporation Units in Q1 2021, selling an estimated $8.36M.
  • DG Capital Management's ten largest holdings make up 44% of its $419M portfolio in Q1 2021.
  • DG Capital Management opened 103 new positions and closed 13 in Q1 2021.
  • DG Capital Management's portfolio value rose 77% quarter-over-quarter to $419M.

Based on DG Capital Management's 13F filing for Q1 2021, filed 13 May 2021.